Dr. Daniel Richard Conlin, MD

Dr. Conlin practices at Golden Gate Endoscopy Center in San Francisco, California.

Dr. Conlin's NPI, 1952439713, was assigned on March 1, 2007. Dr. Conlin graduated from Tufts University School Of Medicine in 1986. Dr. Conlin holds California license G70712.

Dr. Conlin's primary practice is Golden Gate Endoscopy Center, at 3370 Geary Boulevard, First Floor, San Francisco, CA 94118. The practice phone is (415) 379-7500.

Dr. Conlin's primary practice is Golden Gate Endoscopy Center in San Francisco, California. Dr. Conlin is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is Daniel R. Conlin, M.D. & Robert J. Elsen, M.D. Dmand AI also links Dr. Conlin to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Conlin practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Conlin's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Conlin is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Conlin is licensed in California.

Dmand AI lists acid reflux, acute gastroduodenitis, colonoscopy, gastroenteritis, gastrointestinal bleeding, hemorrhoids, intestinal or bowel obstruction and irritable bowel syndrome (IBS) among the conditions Dr. Conlin treats.

CMS data shows 592 Medicare services from Dr. Conlin across 10 procedure codes in 2024, for 422 Medicare patients. Medicare paid $68,366 for them.

CMS counts 422 Medicare patients who saw Dr. Conlin in 2024. The largest group is 65 to 74, with 229 patients. 70% of them have high cholesterol, and 64% have high blood pressure. 17% are also on Medicaid. Their average risk score is 0.83, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Conlin's median patient age at 59, with 36% women.

In 2024, Dr. Conlin wrote 1,301 Medicare Part D claims for 506 patients. 73% of them were for generic drugs. CMS names the drug for 1,134 of them, across 25 drugs with 11 or more claims each, at $493,347 in total drug cost. In 2023, CMS named 1,171 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Conlin for performance year 2024, reported as part of a group. Dr. Conlin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Conlin as offering telehealth. CMS counts 181 procedures of colonoscopy by Dr. Conlin, more than 92% of the clinicians it reports for that procedure.

CMS Open Payments shows 581 general payments to Dr. Conlin from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Abbvie Inc. paid the most, $2,557.

Dr. Conlin graduated from Tufts University School Of Medicine in 1986.

Dr. Conlin is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.